# Inhibition of BIRC5 and MCL-1 as a potential treatment strategy to overcome drug resistance in Mantle Cell Lymphoma

**Authors:** Jeremiah Pfitzer, Sayak Chakravarti, Suman Mazumder, Fengzhi Li, Ujjal Kumar Mukherjee, Amit Kumar Mitra

PMC · DOI: 10.1038/s41408-026-01467-1 · Blood Cancer Journal · 2026-03-11

## Full-text entities

- **Genes:** BIRC5 (baculoviral IAP repeat containing 5) [NCBI Gene 332] {aka API4, EPR-1}, MCL1 (MCL1 apoptosis regulator, BCL2 family member) [NCBI Gene 4170] {aka BCL2L3, EAT, MCL1-ES, MCL1L, MCL1S, Mcl-1}
- **Diseases:** Mantle Cell Lymphoma (MESH:D020522)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12979630/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12979630/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC12979630/full.md

---
Source: https://tomesphere.com/paper/PMC12979630